Oncolys Biopharma Inc 4588.T-JP:Tokyo Stock Exchange

*Data is delayed | Exchange | JPY
Last | 9:02 AM JST
688.00quote price arrow up+2.00 (+0.29%)
Volume
19,300
52 week range
504.00 - 798.00
Loading...
  • Open680.00
  • Day High689.00
  • Day Low680.00
  • Prev Close686.00
  • 52 Week High798.00
  • 52 Week High Date04/01/24
  • 52 Week Low504.00
  • 52 Week Low Date07/12/23

Key Stats

  • Market Cap84.83M
  • Shares Out19.63M
  • 10 Day Average Volume363,611.11
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change21.34

KEY STATS

  • Open680.00
  • Day High689.00
  • Day Low680.00
  • Prev Close686.00
  • 52 Week High798.00
  • 52 Week High Date04/01/24
  • 52 Week Low504.00
  • 52 Week Low Date07/12/23
  • Market Cap84.83M
  • Shares Out19.63M
  • 10 Day Average Volume363,611.11
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change21.34

RATIOS/PROFITABILITY

  • EPS (TTM)-67.10
  • P/E (TTM)-10.25
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Oncolys Biopharma Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Oncolys BioPharma Inc. is a biopharmaceutical company. The Company operates in two business segments. Pharmaceutical business segment is engaged in the research, development, manufacture and marketing of pharmaceuticals. Diagnostic reagents business segment is engaged in the research, development, manufacture and marketing of diagnostic reagents and equipment, as well as the provision of inspection service. The Company's main pipeline includes OBP-301 (Telomelysin), an...
Yasuo Urata
President, Chief Executive Officer, Chairman & CEO of Subsidiary, Representative Director
Address
Toranomon Towers Office
4-1-28, Toranomon
Minato-ku, TKY
105-0001
Japan